Evidence map›Paper›PMID 34975132›Full record

Trial reportIndian journal of pharmacology

Efficacy of

Karri Sowjanya, Chandrashekaran Girish, Chanaveerappa Bammigatti, Nakka Chandrasekhar Prasanna Lakshmi

Open access · greenAbstract readRandomized Controlled Trial
In one paragraph

Trial report in Indian journal of pharmacology. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
3.5field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 30 citations in OpenAlex.

  1. Trial
  2. Article
  3. Review
  4. Article
  5. Review
  6. Article
  7. An insight into the potent medicinal plantThe Nucleus : an international journal of cytology and allied topics · 2022
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Karri SowjanyaDepartment of Pharmacology, Jawaharlal Institute of Postgraduate Medical Education and Research, Puducherry, India.
Chandrashekaran GirishDepartment of Pharmacology, Jawaharlal Institute of Postgraduate Medical Education and Research, Puducherry, India.
Chanaveerappa BammigattiDepartment of Medicine, Jawaharlal Institute of Postgraduate Medical Education and Research, Puducherry, India.
Nakka Chandrasekhar Prasanna LakshmiDepartment of State Indian System of Medicine, Government of Puducherry, Puducherry, India.
Jawaharlal Institute of Post Graduate Medical Education and Research · IN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

introductionPhyllanthus niruri, a traditional herbal medicine, was found to be hepatoprotective as evidenced by several preclinical and clinical studies. However, to the best of our knowledge, there are no clinical trials available to date to evaluate its efficacy in alcoholic hepatitis. MATERIALS AND

methodsThe present study is a block randomized, double-blind, parallel-arm placebo-controlled trial that was designed to assess the efficacy of P. niruri on the liver and renal function parameters, total oxidant and antioxidant levels in alcoholic hepatitis patients in comparison to placebo over a 4-week period. Patients were screened by CAGE questionnaire, and those with a confirmed diagnosis of mild-moderate alcoholic hepatitis based on laboratory findings and Maddrey's discriminant function score were randomly allocated to treatment and placebo arms. Clinical assessments were done at baseline, 2 weeks, and 4 weeks. A total of 454 patients were screened and 100 eligible patients were recruited for the study, and 71 were analyzed using the modified intention-to-treat approach.

resultsSerum levels of liver and renal function parameters failed to demonstrate significant improvement with P. niruri. However, there was a statistically significant increase in the level of total antioxidants with P. niruri (P = 0.034) with an additional appetite stimulant activity (P = 0.03) in 4 weeks.

conclusionA 4-week administration of P. niruri in mild-moderate alcoholic hepatitis patients showed an improvement in the total antioxidant levels with an appetite stimulant activity compared to a placebo.

Indexed as

PhyllanthusAdultAntioxidantsDouble-Blind MethodEnzyme-Linked Immunosorbent AssayFemaleHepatitis, AlcoholicHumansKidney Function TestsLiver Function TestsMalePhytotherapyPlant ExtractsSurveys and QuestionnairesAntioxidantsPlant ExtractsCAGE questionnaireenzyme-linked immunosorbent assayMaddrey's discriminant function scoremitochondrial biogenesisNational Institute for Health and Care Excellence

Identifiers

PMID34975132
PMCPMC8764976
OpenAlexW4200066431

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-SA
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.